Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

吉利德科学公司（Gilead Sciences）与LEO Pharma日前宣布达成战略合作伙伴关系，共同加速LEO Pharma的小分子口服STAT6项目的开发和商业化，旨在为炎症性疾病患者提供潜在治疗方案。

Taiwan Coast Guard says ship that allegedly cut cable crewed by Chinese Request To Download Free Sample of This Strategic Report @ ...

Shareholders request Human Rights Due Diligence to determine whether pharma companies do everything they can to increase drug ...

The colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...

Gilead Sciences Inc (NASDAQ: GILD) is strongly positioned to “change the face of HIV” in 2025, according to its chairman and ...

Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...